Acrivon Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 12.23 M | $21.77 M | 46.63% | 29.23% |
| SANDS CAPITAL VENTURES, LLC | 08/13/2026 | 2.29 M | $4.07 M | 7.85% | 5.47% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 1.17 M | $2.07 M | 37.73% | 2.78% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 952.01 K | $1.69 M | 31.85% | 2.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 888.13 K | $1.58 M | 0.00% | 2.12% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 758.86 K | $1.35 M | 0.06% | 1.81% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 641.50 K | $1.14 M | 64.74% | 1.53% |
| MARSHALL WACE, LLP | 08/13/2026 | 531.86 K | $946.70 K | -5.10% | 1.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 378.90 K | $674.44 K | 138.45% | 0.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 265.24 K | $472.27 K | 12.20% | 0.63% |
| BLACKROCK, INC. | 08/07/2026 | 239.11 K | $425.62 K | 14.44% | 0.57% |
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 200.42 K | $357.00 K | 7.34% | 0.48% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 184.13 K | $327.75 K | 71.24% | 0.44% |
| XTX TOPCO LTD | 08/14/2026 | 178.24 K | $317.27 K | 166.50% | 0.43% |
| JANE STREET GROUP, LLC | 08/14/2026 | 74.65 K | $132.87 K | -68.86% | 0.18% |
| NORTHERN TRUST CORP | 08/13/2026 | 67.20 K | $119.62 K | 37.42% | 0.16% |
| STATE STREET CORP | 09/22/2026 | 67.15 K | $119.52 K | 0.00% | 0.16% |
| UBS GROUP AG | 08/13/2026 | 43.85 K | $78.05 K | 26.61% | 0.10% |
| CITADEL ADVISORS LLC | 09/02/2026 | 41.28 K | $73.47 K | 100.00% | 0.10% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 29.33 K | $52.21 K | 59.73% | 0.07% |
| SPARK INVESTMENT MANAGEMENT LLC | 08/10/2026 | 28.30 K | $50.37 K | 100.00% | 0.07% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2026 | 24.02 K | $42.75 K | 0.00% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 16.41 K | $29.20 K | -0.64% | 0.04% |
| VERDAD ADVISERS, LP | 08/14/2026 | 15.05 K | $26.80 K | 100.00% | 0.04% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 14.92 K | $26.56 K | 1.21% | 0.04% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 13.31 K | $23.69 K | -51.55% | 0.03% |
| AAF WEALTH MANAGEMENT, LLC | 07/17/2026 | 10.68 K | $19.01 K | 0.00% | 0.03% |
| HRT FINANCIAL LP | 08/14/2026 | 10.32 K | $18.00 K | 100.00% | 0.02% |
| MAREX GROUP PLC | 08/14/2026 | 10.00 K | $17.80 K | -50.00% | 0.02% |
| FEDERATED HERMES, INC. | 08/12/2026 | 7.92 K | $14.11 K | 0.00% | 0.02% |
| BARCLAYS PLC | 08/14/2026 | 7.35 K | $13.09 K | 23.80% | 0.02% |
| FMR LLC | 08/13/2026 | 6.96 K | $12.38 K | -26.16% | 0.02% |
| MORGAN STANLEY | 08/13/2026 | 5.23 K | $9.32 K | -85.73% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 1.68 K | $2.99 K | -62.95% | 0.00% |
| CREWS BANK & TRUST | 07/16/2026 | 1.04 K | $1.86 K | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 751 | $1.34 K | 17.71% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 08/10/2026 | 584 | $1.04 K | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 537 | $956 | -15.30% | 0.00% |
| REDWOOD PARK ADVISORS LLC | 08/11/2026 | 500 | $890 | 0.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 481 | $856 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2026 | 400 | $712 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/13/2026 | 326 | $580 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 75 | $134 | 1.35% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 50 | $89 | 1,150.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 6 | $11 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 08/06/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Acrivon Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 54 institutional investors and hedge funds held shares of Acrivon Therapeutics Inc. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 12.23 M
Sands Capital Ventures, LLC: 2.29 M
ACADIAN ASSET MANAGEMENT LLC: 1.17 M
VANGUARD CAPITAL MANAGEMENT LLC: 952,008
WELLINGTON MANAGEMENT GROUP LLP: 888,130
RENAISSANCE TECHNOLOGIES LLC: 758,863
51.15% of Acrivon Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 23.50 M shares in the last 24 months. This purchase volume represents approximately $37.60 M in transactions.